1. Field of the Invention
The present invention relates to apparatus and method for ultrasonically and electromagnetically stimulating treating tissue, for example, traumatized tissue or a bone injury. More particularly, the present invention relates to apparatus and methods which utilize an ultrasonic transducer assembly in combination with an electromagnetic coil assembly to treat tissue.
2. Description of the Related Art
The use of ultrasound to therapeutically treat and evaluate tissue and bone injuries is known. Impinging ultrasonic pulses having appropriate parameters, e.g., frequency, pulse-repetition, and amplitude, for suitable periods of time and at a proper external location adjacent to a tissue or bone injury has been determined to accelerate the natural healing of, for example, tissue tears, bone breaks and fractures.
U.S. Pat. No. 4,530,360 to Duarte describes a basic non-invasive therapeutic technique and apparatus for applying ultrasonic pulses from an operative surface placed on the skin at a location adjacent a bone injury. To apply the ultrasound pulses during treatment an operator must manually hold the applicator in place until the treatment is complete.
The Duarte patent as well as U.S. Pat. No. 5,520,612 to Winder et al. describe ranges of RF signal for creating the ultrasound, ultrasound power density levels, ranges of duration for each ultrasonic pulse, and ranges of ultrasonic pulse frequencies.
U.S. Pat. No. 5,003,965 to Talish et al. relates to an ultrasonic body treatment system having a body-applicator unit connected to a remote control unit by sheathed fiber optic lines. The signal controlling the duration of ultrasonic pulses and the pulse repetition frequency are generated apart from the body-applicator unit. Talish et al. also describes a mounting fixture for attaching the body-applicator unit to a patient so that the operative surface is adjacent the skin location.
While the systems described in these patents relate to methods and apparatus for ultrasonic diagnosis and/or treatment of hard and soft tissue injuries and defects by applying ultrasound to traumatized tissue, it has been demonstrated that the traumatized tissue heals at a faster rate if the acoustic signal envelope of the applied ultrasonic waves is slowly modulated or perturbed. Modulating the signal envelope of the applied ultrasonic waves can be accomplished by either modulating the envelope of the electrical signal to the ultrasound transducer or by modulating the ultrasonic waves in the body by utilizing-controlled electromagnetic induced forces.
It has also been demonstrated that in the case of a non-union injury, i.e., where a bone fracture fails to heal, that electromagnetic-stimulation (E-stim) treatment of the non-union injury produces a therapeutic response in bone tissue. E-stim generally uses at least an external coil to produce a therapeutic pulsed uniform, electromagnetic field at the fracture site. For example, a pair of Helmholtz coils can produce a constant uniform field at the fracture or wound sites, above the local magnetic field in tissue.
It is generally believed that E-stim promotes and accelerates the healing of non-union injuries due to the creation of a magnetic flux density which causes the creation and movement of ionic charges within the bone tissue. Bone tissue is mainly an ionic-fluid-saturated porous medium having various ions in the intercellular and interstitial fluid such as potassium ions, sodium ions, magnesium ions, chloride ions, phosphate ions, carbonate ions, bicarbonate ions and those formed by the dissociation of amino acids, proteins, sugars, nucleotides and enzymes. The application of a pulsed electromagnetic field, i.e.; the controlled combination of electrostatic and magnetic forces, causes these ions to be charged and moved in a particular direction. The ions diffuse within cells at the treatment area, thereby accelerating the healing process.
According to the present disclosure, the healing of tissue, especially non-union injuries, can be further accelerated by combining ultrasound and E-stim. The forces produced by the applied electromagnetic field add a fluctuating or perturbing force, such as a low frequency modulation force, to the propagating ultrasonic or pressure wave to further stimulate the cells at the treatment area and enhance cellular permeability and ionic diffusion. The largest effect on the acoustic field by the electromagnetic field occurs when the direction of the longitudinal waves is perpendicular to the electromagnetic field, or if the transverse (shear) waves are traveling along the magnetic field lines. The electromagnetic field tends to increase the phase velocity of the ultrasonic waves. The associated magnetic force may be held constant or modulated at a low frequency rate.
The present invention provides a combined ultrasonic and E-stim treatment apparatus for therapeutically treating traumatic tissue injuries, especially non-union bone fractures, using combined ultrasound and E-stim. The apparatus includes an ergonomically constructed placement module configured for mounting at least one hybrid ultrasonic transducer assembly having an integral signal generator which provides excitation signals to at least one ultrasonic transducer within the placement module for generating an acoustic field. The placement module further includes at least one electromagnetic coil assembly having at least one electromagnetic coil in proximity to each ultrasonic transducer for generating an electromagnetic field. It is contemplated that timing control circuitry as well as monitoring circuitry for the proper control and operation of the components within the placement module are housed within a main operating unit which may be fit within a pouch worn by the patient or integrally contained in the transducer.
In operation, the placement module is positioned adjacent a part of the patient's body such that the at least one ultrasonic transducer is sonically coupled in position adjacent traumatized tissue and/or an osteochondrial injury. The at least one ultrasonic transducer and at least one electromagnetic coil are then excited by providing an induced signal to these components. The induced signal causes the at least one ultrasonic transducer to impinge ultrasonic pressure waves against the traumatized tissue and/or injury and for the at least one electromagnetic coil to create an electromagnetic field having a magnetic flux density. The frequency of the induced signal can be varied from 1 Hz to 10,000 Hz. The magnetic flux density adds a fluctuating force to the propagating pressure wave in the body to increase the stimulation of the cells in the vicinity of the injury and to enhance cellular permeability which results in an increase in the diffusion of ions into the cells, such as calcium ions in the case of a non-union bone fracture, resulting in increased protein synthesis. An increase in protein synthesis accelerates bone fracture healing and tissue repair. Additionally, it is contemplated to control the average magnetic flux density, pulse repetition rate, and pulse width of the induced signal for optimal osteogenic stimulation.
Preferably, the main operating unit has an internal power source for powering the signal generator of the ultrasonic transducer assembly, a display for displaying treatment sequence data, a keypad coupled to the signal generator for permitting user operation and/or entry of data. The signal generator includes circuitry having a processor, means for generating a pulsed control signal, and a switch coupled to the processor for regulating the pulsed control signal. The main operating unit further has an alarm for indicating to the user that the treatment time has expired. The alarm is coupled to the processor such that when ultrasonic and E-stim treatment is completed the processor activates the alarm and terminates the induced signal to the components within the placement module.
The present invention also provides a kit for combined ultrasonic and E-stim treatment of traumatized tissue and osteochondrial injuries. The kit includes an ultrasonic transducer assembly having an ultrasonic transducer and signal generator circuitry, an electromagnetic coil assembly having an electromagnetic coil and operating circuitry, a placement module configured for placement therein of the ultrasonic transducer and electromagnetic coil assemblies, and a main operating unit (MOU) or controller coupled to the placement module via a cable. The MOU has an internal power source thereby providing patient mobility. A MOU envisioned for use with the present invention is described in U.S. Pat. No. 5,556,372 to Talish et al. which is hereby incorporated by reference.
The present invention further provides a method for combined ultrasonic and E-stim treatment of traumatized tissue and/or osteochondrial injuries. The method entails the steps of locating the site of the injury; positioning a placement module containing at least one ultrasonic transducer assembly and at least one electromagnetic coil assembly adjacent to the injury such that the at least one ultrasonic transducer and at least one electromagnetic coil of the at least one ultrasonic transducer and at least one electromagnetic coil assemblies, respectively, are in proximity to the injury; activating the at least one ultrasonic transducer and the at least one electromagnetic coil for simultaneously propagating at least one ultrasonic pressure wave towards the injury and creating an electromagnetic field for adding a fluctuating force to the propagating pressure wave.
In an alternative embodiment, a placement module is provided for securing a plurality of ultrasonic transducers and a plurality of electromagnetic coils thereto in a plurality of configurations. The placement module is then secured in proximity to traumatized tissue and/or an osteochondrial injury to provide ultrasonic and E-stim treatment.
Preferred embodiments of the invention are described below with reference to the drawings, which are described as follows:
Preferred embodiments of the present invention will be described in detail with reference to the attached drawings. Like reference numerals denote the same or similar components in the drawings.
The ultrasonic and E-stim treatment apparatus and methods of the present invention are used for the surgically non-invasive application of ultra high-frequency acoustic energy and magnetic flux density in the treatment of traumatized tissue and/or osteochondrial injuries. Even though this detailed description discusses the treatment of traumatized tissue and/or osteochondrial injuries, the ultrasound and E-stim treatment apparatus can be used to treat osteochondrial defects caused by e.g., medication, infection or metabolic processes.
1. Pulsed Low Intensity Ultrasound Excitation
Ultrasound wave propagation in tissue exerts a unidirectional radiation force on all absorbing and reflecting obstacles in its path, even at the microstructural level. Low-intensity ultrasound refers to those power levels that just exceed biological thresholds which trigger or evoke general biological regulatory reactions. Although too low to produce direct measurable biological effects, clinical results have established that low intensity ultrasound is sufficient to invoke biological healing processes.
Since the early sixties, the specific physical and biological mechanisms behind the thereapeutic effectiveness of low intensity ultrasound have been extensively investigated. For spatial average-temporal average (SATA) intensities from 0.1–0.5 W/cm2, it is possible to produce the non-thermal, high stress mechanisms of acoustic streaming and cavitation. In vitro tests on isolated fibroblast cells have shown that the effects of ultrasound on the cells are pressure sensitive, suggesting a stable cavitation mechanism. The resulting bubble oscillations, possibly including acoustic microstreaming, can generate high shear stress on the cell membrane, which can affect the cell's permeability to sodium and calcium ions. The increase in cell permeability may result in an increase in calcium uptake, and increase in protein and DNA synthesis in fibroblasts, and account for the observed activation of macrophages. The production of fibroblasts and macrophages characterizes the normal fracture repair process.
For SATA intensities below 0.1 W/cm2, stable cavitation and acoustic micro-streaming seem quite unlikely. In vivo test results indicate that a low SATA intensity from 30–50 mW/cm2 is highly effective in stimulation bone fracture repair. These results support the thesis that ultrasonically-induced mechanical vibrations tend to increase the permeability of the cell membrane to calcium ions. Preliminary clinical results indicate that the initial result of applying pulsed, low intensity ultrasound to traumatized tissue is to increase blood flow in the local region. It is proposed that the increased vascularity and the micromechanical fluid pressure appears to produce an increase in cellular calcium uptake, resulting in increased protein synthesis, thereby accelerating bone fracture healing and tissue repair.
2. Significance of Ultrasound
Modulation to Stimulate Vascularity
Test results have shown that there is an increase in vascularity produced with the application of ultrasound to traumatized tissue. In treating bone fractures, the increase in blood flow to the callus, for example, may prove significant in accelerating bone healing. The test results referred to were obtained with an acoustic longitudinal wave and a constant (0 Hz) modulation envelope. It was clearly established that bone healing initially occurs in the periosteal region, followed by healing within the fracture itself (endosteal healing). The increased vascular flow due to ultrasound stimulation occurred in the region of the periosteum. It is proposed that the acoustic wave stimulates the exposed nerve endings of the periosteum, thereby stimulating local vascularization. The acoustic wave is preferably a constant envelope sine wave at a carrier frequency of 1.5 MHZ and a repetition frequency of 1.0 kHz.
A slowly modulated acoustic signal envelope, at a rate less than 100 Hz, may prove to be more osteogenic, both in the fracture gap and on the periosteum. It has been demonstrated that the micromechanical stimuli (0.5 Hz for 17 minutes, daily) significantly improves the healing of tibial fractures. This accelerated healing process has been correlated with the promotion of fracture revascularization. The modulation of the excitation may be accomplished by either modulating the envelope of the electrical signal to the ultrasound transducer or by modulating the pressure wave in the body, utilizing controlled electromagnetic induced forces.
3. Low-Frequency Electromagnetic Excitation
In cases where the fracture fails to heal, referred to as a non-union, the most common treatment is surgery or electromagnetic-stimulation (E-stim). As discussed above, E-stim uses an external coil to produce a therapeutic pulsed electromagnetic field at the fracture site.
4. Combined Ultrasonic and Electromagnetic Stimulation
Specifically, the combined ultrasonic and E-stim treatment methods and apparatus of the present invention generate and control the spatial distribution of a non-uniform, time-varying, directionally-oriented electromagnetic field to produce an ionic current and electric voltage, relative to the spatial and temporal generation and control of a time-varying, directionally-oriented non-uniform acoustic pressure wave, in living tissue. The main physical factors that characterize ultrasound propagation in tissue are mechanical, affecting the particle displacement, velocity, acceleration, and pressure at the microstructural level.
In preferred embodiments of the present invention, the forces produced by the applied electromagnetic field are employed to add a perturbing or fluctuating force, such as a low frequency modulation force, to the propagating pressure wave in the body to increase the stimulation of the cells in the vicinity of the injury and to enhance cellular permeability which results in an increase in the diffusion of ions into the cells, such as calcium ions in the case of a non-union bone fracture, resulting in increased protein synthesis. As indicated above, an increase in protein synthesis accelerates bone fracture healing and tissue repair.
The low frequency perturbation of the propagating pressure wave can be produced by positioning the electromagnetic coil in a wide variety of orientations relative to the direction of the propagating pressure wave. The largest effect on the pressure wave occurs when the direction of the longitudinal pressure wave is perpendicular to the magnetic field, or if the transverse (shear) waves are traveling along the magnetic field lines. In this case, the magnetic field tends to increase the phase velocity of the sound wave. The associated magnetic force may be held constant or modulated at a low frequency rate by controlling the magnitude of an induced signal to the electromagnetic coil.
Consider the effect of a magnetic field on the propagation of a sound wave in a conducting fluid, such as the soft tissue-bone complex. Bone tissue is mainly an ionic-fluid-saturated porous medium having various ions in the intercellular and interstitial fluid, such as potassium ions, sodium ions, magnesium ions, chloride ions, phosphate ions, carbonate ions, bicarbonate ions and those formed by the dissociation of amino acids, proteins, sugars, nucleotides and enzymes. The movement of charged ions by the controlled combination of electrostatic, magnetic and acoustic radiation forces can promote and accelerate tissue healing. The interrelationships between these physical entities can be depicted by the general acoustic wave equation in a solid, homogeneous medium.
It is well known that the magnetic force F on a positive charge q moving with a velocity v in a magnetic field of flux density B is given by the vector product F=qv×B. The vector product gives the same direction for F as does the classic Fleming's left-hand rule and establishes that F is perpendicular to B. If the longitudinal acoustic waves are propagated in the direction of the magnetic flux, there is no effect on the acoustic field. As indicated above, the largest effect to the acoustic field occurs when the direction of the longitudinal waves is perpendicular to the magnetic field, or if the transverse (shear) waves are traveling along the magnetic field lines.
In general, the acoustic waves can travel at an arbitrary angle with respect to the magnetic field flux lines. When this occurs, the nature of the resulting acoustic wave will depend markedly on whether the fluid velocity is parallel with or perpendicular to the plane established by k (wavenumber) and B. If the particle velocity is perpendicular to the k-B plane, then the wave motion will be transverse, having a velocity equal to B cos θ/√{dot over (ρ)}, where θ is the angle between the direction of propagation and the magnetic field, and ρ is the fluid density. If the particle velocity vector lies in the k-B plane, then the wave mode will contain both a transverse and a longitudinal wave, corresponding to the particle velocity components perpendicular and parallel with k, respectively. It is shown that a density fluctuation is produced only if there is a velocity component in the direction of propagation and the perturbation in the magnetic field is always perpendicular to k.
The various embodiments of the present invention include an ergonomically constructed placement module having a strap or other fastening means for being secured adjacent an injured part of a patient's body. At least one ultrasonic transducer assembly and at least one electromagnetic coil assembly are attached to or housed within the placement module and properly positioned in proximity to the traumatized tissue and/or osteochondrial injury. The at least one ultrasonic transducer assembly includes at least one ultrasonic transducer and the at least one electromagnetic coil assembly includes at least one electromagnetic coil. Different types of ultrasonic transducers and signals can be provided, such as those described and schematically depicted in U.S. Pat. No. 5,520,612 to Winder et al. which is hereby incorporated by reference. Additionally, ultrasonic transducers can be used such as those described and illustrated in U.S. patent application Ser. No. 09/040,155 filed on Mar. 17, 1998, the contents of which are incorporated herein by reference.
The apparatus preferably uses electromagnetic field coil configurations to produce asymmetric, non-uniform or time-varying fields which can be used for selective spatial stimulation in tissue. In the embodiments described below the frequency of the induced signal to the at least one ultrasonic transducer and at least one electromagnetic coil can be varied from 1 Hz to 10 KHz. It is preferred that for optimal osteogenic stimulation, in the treatment of non-union bone fractures, that the average magnetic flux density, pulse repetition rate, and pulse width of the induced signal be controlled. Precise control of the average magnetic flux implies considering the combined magnetic field of the applied magnetic field via the at least one electromagnetic coil and the local magnetic fields. The latter includes the Earth's magnetic field and the effects of ferromagnetic materials in the vicinity which create additional magnetic flux that flows through tissue.
The apparatus also preferably utilizes a portable, ergonomically constructed main operating unit (MOU) having an internal power source which is worn by the patient. The internal power source provides control signals to the ultrasonic transducers and electromagnetic coils at the placement module. It is preferred that the electromagnetic coils produce time-varying, non-uniform electromagnetic fields. The MOU which is utilized is preferably the one described in U.S. Pat. No. 5,556,372 to Talish et al.; the contents of which are incorporated herein by reference. The ultrasonic transducers and associated circuitry preferably used are described in U.S. application Ser. No. 09/040,157; the contents of which are incorporated-herein by reference.
Turning to the figures, in particular
Referring to
With reference to
With reference to
The ultrasonic transducer assembly 26 and electromagnetic coil assembly 28 for these embodiments are coupled to the MOU 12 by cable 16. The cable 16 is preferably a multiconductor cable capable of transmitting relatively low frequency RF or optical signals, as well as digital signals. The cable 16 may include coaxial cable or other types of suitable shielded cable. Alternatively, the cable 16 may include fiber optic cable for transmitting optical signals.
The signals from the MOU 12 may be transmitted continuously or as a series of pulses. It is contemplated that a voltage magnitude of the signals to the ultrasonic transducer 30 be varied to vary a transmission power of the propagated ultrasonic waves. Further, it is contemplated that a voltage magnitude of the signal to the electromagnetic coil 32 be varied to vary the magnetic flux density.
With reference to
In
In
With reference to
The ultrasonic transducer assembly 36 and electromagnetic coil assembly 38 are coupled to a MOU (not shown) similar to MOU 12 shown in
With reference to
In
As shown in
With reference to
The electromagnetic coil assembly 28 and the ultrasonic transducer assembly 26 are individually coupled by cables 62 and 64, respectively, to a MOU (not shown). The MOU can be similar to MOU 12 of the embodiment shown in
With reference to
In
In
In
In operation the placement band 72 is affixed in proximity to the traumatized tissue or osteochondrial injury. The ultrasonic transducers 76 and the electromagnetic coils 80 are then activated for a predetermined amount of time to impinge modulated acoustic waves at the injury site. It is contemplated that the electromagnetic coils 80 can be positioned in a variety of positions to control the amount of modulation as discussed above with reference to several embodiments. It is further contemplated to individually drive the ultrasonic transducers 76 and the electromagnetic coils 80 at different times and at varying periods.
It is additionally contemplated to construct the placement band 72 from suitable conductive plastics, such as conductive ABS plastics with either carbon, stainless steel, nickel or aluminum fibers to forego the use of wires for connecting each ultrasonic transducer and electromagnetic coil assembly to a specific cable. In such an embodiment, the conductive placement band would be used to electrically connect the ultrasonic transducer: and electromagnetic coil assemblies to an MOU via a single cable.
It is also contemplated to provide each of the embodiments of the present invention as a kit for combined ultrasonic and E-stim treatment of traumatized tissue and osteochondrial injuries. The kit can include the ultrasonic transducer assembly having the ultrasonic transducer and signal generator circuitry, the electromagnetic coil assembly having the electromagnetic coil and operating circuitry, the placement module configured for placement therein of the ultrasonic transducer and electromagnetic coil assemblies, and the main operating unit (MOU) coupled to the placement module.
For all the embodiments disclosed herein, it is contemplated that an ultrasound conducting gel be positioned between the placement modules of the embodiments herein and the injured part of the patient's body to prevent attenuation of the ultrasonic waves. It is also contemplated that one or more transducers can be converted to receive reflected diagnostic data from the treatment site. This permits real time evaluation of the injury site and healing process.
Block diagrams of first and second preferred embodiments of the ultrasonic transducer assembly circuitry is shown by FIGS. 6 and 6A in U.S. Pat. No. 5,556,372, the contents of which are incorporated herein by reference.
It will be understood that various modifications can be made to the various embodiments of the present invention herein disclosed without departing from its spirit and scope. For example, various modifications may be made in the structural configuration of the placement modules and the configuration of the ultrasonic transducer and electromagnetic coil assemblies. Therefore, the above description should not be construed as limiting the invention but merely as presenting preferred embodiments of the invention. Those skilled in the art will envision other modifications within the scope and spirit of the present invention as defined by the claims presented below.
This application claims priority to a U.S. Provisional Application No. 60/135,224 filed on May 21, 1999 by Talish et al., the contents of which are incorporated herein by reference,
Number | Name | Date | Kind |
---|---|---|---|
1063782 | Dickey | Jun 1913 | A |
1604870 | Asman | Oct 1926 | A |
2914829 | Willemain | Dec 1959 | A |
2920853 | Bufogle | Jan 1960 | A |
3117571 | Fry et al. | Jan 1964 | A |
3134451 | Hanssen | May 1964 | A |
3193034 | Hutchinson et al. | Jul 1965 | A |
3241375 | Canzoneri | Mar 1966 | A |
3304036 | Davis | Feb 1967 | A |
3310049 | Clynes | Mar 1967 | A |
3433663 | Underwood | Mar 1969 | A |
3499437 | Balamuth | Mar 1970 | A |
3521225 | Kursman et al. | Jul 1970 | A |
3550586 | Balamuth | Dec 1970 | A |
3575050 | Lynnworth | Apr 1971 | A |
3594993 | Heyse | Jul 1971 | A |
3664626 | Sneller | May 1972 | A |
3701352 | Bosworth | Oct 1972 | A |
3714619 | Morgan et al. | Jan 1973 | A |
3729162 | Salvato | Apr 1973 | A |
3760799 | Crowson | Sep 1973 | A |
3767195 | Dimick | Oct 1973 | A |
3828769 | Mettler | Aug 1974 | A |
3855638 | Pilliar | Dec 1974 | A |
3890953 | Kraus et al. | Jun 1975 | A |
3961380 | Garr | Jun 1976 | A |
3986212 | Sauer | Oct 1976 | A |
4037592 | Kronner | Jul 1977 | A |
4105017 | Ryaby et al. | Aug 1978 | A |
4108165 | Kopp et al. | Aug 1978 | A |
4127125 | Takemoto et al. | Nov 1978 | A |
4141524 | Corvese, Jr. | Feb 1979 | A |
4164794 | Spector et al. | Aug 1979 | A |
4170045 | Estes | Oct 1979 | A |
4176664 | Kalish | Dec 1979 | A |
4195517 | Kalinoski et al. | Apr 1980 | A |
4206516 | Pilliar | Jun 1980 | A |
4216766 | Duykers et al. | Aug 1980 | A |
4227111 | Cross et al. | Oct 1980 | A |
4229992 | McKee et al. | Oct 1980 | A |
4233477 | Rice et al. | Nov 1980 | A |
4266532 | Ryaby et al. | May 1981 | A |
4266533 | Ryaby et al. | May 1981 | A |
4269797 | Mikiya et al. | May 1981 | A |
4291025 | Pellico | Sep 1981 | A |
4296753 | Goudin | Oct 1981 | A |
4312536 | Lloyd | Jan 1982 | A |
4315503 | Ryaby et al. | Feb 1982 | A |
4315514 | Drewes et al. | Feb 1982 | A |
4347645 | Iseki | Sep 1982 | A |
4351069 | Ballintyn et al. | Sep 1982 | A |
4355428 | Deloison et al. | Oct 1982 | A |
4358105 | Sweeney, Jr. | Nov 1982 | A |
4361154 | Pratt, Jr. | Nov 1982 | A |
4365359 | Raab | Dec 1982 | A |
4383533 | Lovelace et al. | May 1983 | A |
4407044 | Iseki | Oct 1983 | A |
4410158 | Maffel | Oct 1983 | A |
4421119 | Pratt, Jr. | Dec 1983 | A |
4431038 | Rome | Feb 1984 | A |
4440025 | Hayakawa et al. | Apr 1984 | A |
4441486 | Pounds | Apr 1984 | A |
4446586 | Reed et al. | May 1984 | A |
4452326 | Hanssen et al. | Jun 1984 | A |
4467659 | Baumoel | Aug 1984 | A |
4476847 | Taenzer et al. | Oct 1984 | A |
4476874 | Taenzer et al. | Oct 1984 | A |
4482942 | Blaisdell et al. | Nov 1984 | A |
4511921 | Harlan et al. | Apr 1985 | A |
4530360 | Duarte | Jul 1985 | A |
4536894 | Galante et al. | Aug 1985 | A |
4542539 | Rowe, Jr. et al. | Sep 1985 | A |
4542744 | Barnes et al. | Sep 1985 | A |
4550714 | Talish | Nov 1985 | A |
4556066 | Semrow | Dec 1985 | A |
4557148 | Akiyama | Dec 1985 | A |
4570487 | Gruber | Feb 1986 | A |
4570640 | Barsa | Feb 1986 | A |
4570927 | Petrofsky et al. | Feb 1986 | A |
4573996 | Kwiatek et al. | Mar 1986 | A |
4594662 | Devaney | Jun 1986 | A |
4612160 | Donlevy et al. | Sep 1986 | A |
4627429 | Tsuk | Dec 1986 | A |
4630323 | Sage et al. | Dec 1986 | A |
4644942 | Sump | Feb 1987 | A |
4646725 | Moasser | Mar 1987 | A |
4657543 | Langer et al. | Apr 1987 | A |
4669483 | Hepp et al. | Jun 1987 | A |
4677438 | Michiguchi et al. | Jun 1987 | A |
4680967 | Rost | Jul 1987 | A |
4687195 | Potts | Aug 1987 | A |
4689986 | Carson et al. | Sep 1987 | A |
4708127 | Abdelghani | Nov 1987 | A |
4710655 | Masaki | Dec 1987 | A |
4725272 | Gale | Feb 1988 | A |
4726099 | Card | Feb 1988 | A |
4763661 | Sommer et al. | Aug 1988 | A |
4770184 | Greene, Jr. et al. | Sep 1988 | A |
4774959 | Palmer et al. | Oct 1988 | A |
RE32782 | Pratt, Jr. | Nov 1988 | E |
4782822 | Ricken | Nov 1988 | A |
4787070 | Suzuki et al. | Nov 1988 | A |
4787888 | Fox | Nov 1988 | A |
4792336 | Hlavacek et al. | Dec 1988 | A |
4802477 | Gabbay | Feb 1989 | A |
4830015 | Okazaki | May 1989 | A |
4836316 | Carnevale et al. | Jun 1989 | A |
4855911 | Lele et al. | Aug 1989 | A |
4858599 | Halpern | Aug 1989 | A |
4867169 | Machida et al. | Sep 1989 | A |
4891849 | Robinson | Jan 1990 | A |
4905671 | Senge et al. | Mar 1990 | A |
4913157 | Pratt, Jr. et al. | Apr 1990 | A |
4917092 | Todd et al. | Apr 1990 | A |
4917376 | Lo | Apr 1990 | A |
4920966 | Hon et al. | May 1990 | A |
4926870 | Brandenburger | May 1990 | A |
4928959 | Bassett et al. | May 1990 | A |
4930358 | Motegi et al. | Jun 1990 | A |
4932951 | Liboff et al. | Jun 1990 | A |
4933230 | Card et al. | Jun 1990 | A |
4936303 | Detwiler et al. | Jun 1990 | A |
4941474 | Pratt, Jr. | Jul 1990 | A |
4947853 | Hon | Aug 1990 | A |
4979501 | Valchanov et al. | Dec 1990 | A |
4982730 | Lewis, Jr. | Jan 1991 | A |
4984462 | Hass, Jr. et al. | Jan 1991 | A |
4986275 | Ishida et al. | Jan 1991 | A |
4993413 | McLeod et al. | Feb 1991 | A |
4995883 | Demane et al. | Feb 1991 | A |
5000183 | Bonnefous | Mar 1991 | A |
5000442 | Dalebout et al. | Mar 1991 | A |
5003965 | Talish et al. | Apr 1991 | A |
5004476 | Cook | Apr 1991 | A |
5016641 | Schwartz | May 1991 | A |
5018285 | Zolman et al. | May 1991 | A |
5046484 | Bassett et al. | Sep 1991 | A |
5054490 | Rossman et al. | Oct 1991 | A |
5067940 | Liboff et al. | Nov 1991 | A |
5080672 | Bellis | Jan 1992 | A |
5088976 | Liboff et al. | Feb 1992 | A |
5099702 | French | Mar 1992 | A |
5100373 | Liboff et al. | Mar 1992 | A |
5103806 | McLeod et al. | Apr 1992 | A |
5106361 | Liboff et al. | Apr 1992 | A |
5107853 | Plyter | Apr 1992 | A |
5108452 | Fallin | Apr 1992 | A |
5133420 | Smith | Jul 1992 | A |
5134999 | Osipov | Aug 1992 | A |
5139498 | Astudillo Ley | Aug 1992 | A |
5140988 | Stouffer et al. | Aug 1992 | A |
5143069 | Kwon et al. | Sep 1992 | A |
5143073 | Dory | Sep 1992 | A |
5154189 | Oberlander | Oct 1992 | A |
5163598 | Peters et al. | Nov 1992 | A |
5172692 | Kulow et al. | Dec 1992 | A |
5178134 | Vago | Jan 1993 | A |
5181512 | Viebach et al. | Jan 1993 | A |
5184605 | Grzeszykowski | Feb 1993 | A |
5186162 | Talish et al. | Feb 1993 | A |
5191880 | McLeod et al. | Mar 1993 | A |
5197475 | Antich et al. | Mar 1993 | A |
5201766 | Georgette | Apr 1993 | A |
5209221 | Riedlinger | May 1993 | A |
5211160 | Talish et al. | May 1993 | A |
5230334 | Klopotek | Jul 1993 | A |
5230345 | Curran et al. | Jul 1993 | A |
5230646 | Thorup | Jul 1993 | A |
5230921 | Waltonen et al. | Jul 1993 | A |
5235981 | Hascoet et al. | Aug 1993 | A |
5254123 | Bushey | Oct 1993 | A |
5259384 | Kaufman et al. | Nov 1993 | A |
5269306 | Warnking et al. | Dec 1993 | A |
5273028 | McLeod et al. | Dec 1993 | A |
5280728 | Sato et al. | Jan 1994 | A |
5284143 | Rattner | Feb 1994 | A |
5285788 | Arenson et al. | Feb 1994 | A |
5295931 | Dreibelbis et al. | Mar 1994 | A |
5301683 | Durkan | Apr 1994 | A |
5307284 | Brunfeldt et al. | Apr 1994 | A |
5309898 | Kaufman et al. | May 1994 | A |
5310408 | Schryver et al. | May 1994 | A |
5314401 | Tepper | May 1994 | A |
5316000 | Chapelon et al. | May 1994 | A |
5318561 | McLeod et al. | Jun 1994 | A |
5318779 | Hakamatsuka et al. | Jun 1994 | A |
5322067 | Prater et al. | Jun 1994 | A |
5323769 | Bommannan et al. | Jun 1994 | A |
5327890 | Matura et al. | Jul 1994 | A |
5330481 | Hood et al. | Jul 1994 | A |
5330489 | Green et al. | Jul 1994 | A |
5334214 | Putnam | Aug 1994 | A |
5339804 | Kemp | Aug 1994 | A |
5340510 | Bowen | Aug 1994 | A |
5351389 | Erickson et al. | Oct 1994 | A |
5363850 | Soni et al. | Nov 1994 | A |
5366465 | Mirza | Nov 1994 | A |
5367500 | Ng | Nov 1994 | A |
5368044 | Cain et al. | Nov 1994 | A |
5376065 | McLeod et al. | Dec 1994 | A |
5380269 | Urso | Jan 1995 | A |
5386830 | Powers et al. | Feb 1995 | A |
5393296 | Rattner | Feb 1995 | A |
5394877 | Orr et al. | Mar 1995 | A |
5394878 | Frazin et al. | Mar 1995 | A |
5398290 | Brethour | Mar 1995 | A |
5400795 | Murphy et al. | Mar 1995 | A |
5405389 | Conta et al. | Apr 1995 | A |
5409446 | Rattner | Apr 1995 | A |
RE34959 | Potts | May 1995 | E |
5413550 | Castel | May 1995 | A |
5415167 | Wilk | May 1995 | A |
5417215 | Evans et al. | May 1995 | A |
5424550 | Kawano et al. | Jun 1995 | A |
5425954 | Thompson et al. | Jun 1995 | A |
5431612 | Holden | Jul 1995 | A |
5434827 | Bolorforosh | Jul 1995 | A |
5441051 | Hileman et al. | Aug 1995 | A |
5441058 | Fareed | Aug 1995 | A |
5448994 | Iinuma | Sep 1995 | A |
5460595 | Hall et al. | Oct 1995 | A |
5466215 | Lair et al. | Nov 1995 | A |
5468220 | Sucher | Nov 1995 | A |
5476438 | Edrich et al. | Dec 1995 | A |
5478306 | Stoner | Dec 1995 | A |
5484388 | Bassett et al. | Jan 1996 | A |
5492525 | Gibney | Feb 1996 | A |
5495846 | Uehara et al. | Mar 1996 | A |
5496256 | Bock et al. | Mar 1996 | A |
5501657 | Feero | Mar 1996 | A |
5507800 | Strickland | Apr 1996 | A |
5507830 | DeMane et al. | Apr 1996 | A |
5509933 | Davidson et al. | Apr 1996 | A |
5520612 | Winder et al. | May 1996 | A |
5524624 | Tepper et al. | Jun 1996 | A |
5526815 | Granz et al. | Jun 1996 | A |
5541489 | Dunstan | Jul 1996 | A |
5547459 | Kaufman et al. | Aug 1996 | A |
5556372 | Talish et al. | Sep 1996 | A |
5578060 | Pohl et al. | Nov 1996 | A |
5615466 | Safari et al. | Apr 1997 | A |
5626554 | Ryaby et al. | May 1997 | A |
5626630 | Markowitz et al. | May 1997 | A |
5630837 | Crowley | May 1997 | A |
D380440 | Talish et al. | Jul 1997 | S |
5644093 | Wright et al. | Jul 1997 | A |
5648941 | King | Jul 1997 | A |
5656016 | Ogden | Aug 1997 | A |
5665141 | Vago | Sep 1997 | A |
5680863 | Hossack et al. | Oct 1997 | A |
5690608 | Watanabe et al. | Nov 1997 | A |
5691960 | Gentilman et al. | Nov 1997 | A |
5699803 | Carodiskey | Dec 1997 | A |
5702353 | Guzzini et al. | Dec 1997 | A |
5702389 | Taylor et al. | Dec 1997 | A |
5706818 | Gondo | Jan 1998 | A |
5708236 | Shaanan et al. | Jan 1998 | A |
5721400 | Haraldsson et al. | Feb 1998 | A |
5725482 | Bishop | Mar 1998 | A |
5728095 | Taylor et al. | Mar 1998 | A |
5730705 | Talish et al. | Mar 1998 | A |
5738625 | Gluck | Apr 1998 | A |
5741317 | Ostrow | Apr 1998 | A |
5743862 | Izumi | Apr 1998 | A |
5752924 | Kaufman et al. | May 1998 | A |
5755746 | Lifshey et al. | May 1998 | A |
5762616 | Talish | Jun 1998 | A |
5779600 | Pape | Jul 1998 | A |
5785656 | Chiabrera et al. | Jul 1998 | A |
5818149 | Safari et al. | Oct 1998 | A |
5829437 | Bridges | Nov 1998 | A |
5843741 | Wong et al. | Dec 1998 | A |
5856622 | Yamamoto et al. | Jan 1999 | A |
5868649 | Erickson et al. | Feb 1999 | A |
5871446 | Wilk | Feb 1999 | A |
5886302 | Germanton et al. | Mar 1999 | A |
5891143 | Taylor et al. | Apr 1999 | A |
5899425 | Corey Jr. et al. | May 1999 | A |
5904659 | Duarte et al. | May 1999 | A |
5906580 | Kline-Schoder et al. | May 1999 | A |
5954675 | Dellagatta | Sep 1999 | A |
5957814 | Eschenbach | Sep 1999 | A |
5962790 | Lynnworth et al. | Oct 1999 | A |
5971984 | Taylor et al. | Oct 1999 | A |
5997490 | McLeod et al. | Dec 1999 | A |
6019710 | Dalebout et al. | Feb 2000 | A |
6022349 | McLeod et al. | Feb 2000 | A |
6028066 | Unger | Feb 2000 | A |
6030386 | Taylor et al. | Feb 2000 | A |
6048323 | Hon | Apr 2000 | A |
6050943 | Slayton et al. | Apr 2000 | A |
6061597 | Rieman et al. | May 2000 | A |
6065350 | Hill et al. | May 2000 | A |
6068596 | Weth et al. | May 2000 | A |
6080088 | Petersen et al. | Jun 2000 | A |
6082181 | Greenwood | Jul 2000 | A |
6086078 | Ferez | Jul 2000 | A |
6088613 | Unger | Jul 2000 | A |
6093135 | Huang | Jul 2000 | A |
6105431 | Duffill et al. | Aug 2000 | A |
6165144 | Talish et al. | Dec 2000 | A |
6179797 | Brotz | Jan 2001 | B1 |
6190336 | Duarte et al. | Feb 2001 | B1 |
6206843 | Iger et al. | Mar 2001 | B1 |
6213958 | Winder | Apr 2001 | B1 |
6234975 | McLeod et al. | May 2001 | B1 |
6234990 | Rowe et al. | May 2001 | B1 |
6258020 | Lopez | Jul 2001 | B1 |
6261221 | Tepper et al. | Jul 2001 | B1 |
6261249 | Talish et al. | Jul 2001 | B1 |
6264650 | Hovda et al. | Jul 2001 | B1 |
6273864 | Duarte | Aug 2001 | B1 |
6311402 | Brandl et al. | Nov 2001 | B1 |
6322527 | Talish | Nov 2001 | B1 |
6355006 | Ryaby et al. | Mar 2002 | B1 |
6360027 | Hossack et al. | Mar 2002 | B1 |
6394955 | Perlitz | May 2002 | B1 |
6397683 | Hagenmeyer et al. | Jun 2002 | B1 |
6406443 | Talish | Jun 2002 | B1 |
6436060 | Talish | Aug 2002 | B1 |
6443898 | Unger | Sep 2002 | B1 |
6464687 | Ishikawa et al. | Oct 2002 | B1 |
6503214 | Talish | Jan 2003 | B1 |
6524261 | Talish et al. | Feb 2003 | B2 |
6685656 | Duarte et al. | Feb 2004 | B1 |
6733468 | Talish | May 2004 | B2 |
6932308 | Talish et al. | Aug 2005 | B2 |
6960173 | Babaev | Nov 2005 | B2 |
7108663 | Talish | Sep 2006 | B2 |
7211060 | Talish | May 2007 | B1 |
20020016557 | Duarte | Feb 2002 | A1 |
20020068871 | Mendlein et al. | Jun 2002 | A1 |
20020103448 | Babaev | Aug 2002 | A1 |
20020115960 | Redding, Jr. | Aug 2002 | A1 |
20020156400 | Babaev | Oct 2002 | A1 |
20020190136 | Babaev | Dec 2002 | A1 |
20030013956 | Michaeli | Jan 2003 | A1 |
20030153846 | Talish | Aug 2003 | A1 |
20030153849 | Huckle | Aug 2003 | A1 |
20040127790 | Lang et al. | Jul 2004 | A1 |
20050096548 | Talish | May 2005 | A1 |
20060106424 | Bachem | May 2006 | A1 |
Number | Date | Country |
---|---|---|
19950292 | Feb 2000 | AU |
1328485 | Apr 1994 | CA |
3639263 | Jun 1987 | DE |
4111055 | Oct 1991 | DE |
19613425 | Jan 1997 | DE |
29811185 | Oct 1998 | DE |
0 181 506 | May 1986 | EP |
331 348 | Sep 1989 | EP |
0 536 875 | Apr 1993 | EP |
0 679 371 | Nov 1995 | EP |
0 695 559 | Feb 1996 | EP |
0 965 839 | Dec 1999 | EP |
2156983 | Oct 1985 | GB |
2277448 | Nov 1994 | GB |
2 303 552 | Feb 1997 | GB |
SHO 62-47359 | Mar 1987 | JP |
HEI 4-82567 | Mar 1992 | JP |
HEI 4-82568 | Mar 1992 | JP |
HEI 4-82569 | Mar 1992 | JP |
HEI 5-269159 | Oct 1993 | JP |
WO 8503449 | Aug 1985 | WO |
WO8800845 | Feb 1988 | WO |
WO8802250 | Apr 1988 | WO |
WO9006720 | Jun 1990 | WO |
WO9413411 | Jun 1994 | WO |
WO9503744 | Feb 1995 | WO |
WO9533416 | Dec 1995 | WO |
WO9625112 | Aug 1996 | WO |
WO9625888 | Aug 1996 | WO |
WO9733649 | Sep 1997 | WO |
WO9810729 | Mar 1998 | WO |
WO9834578 | Aug 1998 | WO |
WO9847570 | Oct 1998 | WO |
WO9918876 | Apr 1999 | WO |
WO9922652 | May 1999 | WO |
WO9948621 | Sep 1999 | WO |
WO9956829 | Nov 1999 | WO |
WO9958080 | Nov 1999 | WO |
WO 0003663 | Jan 2000 | WO |
WO 0028925 | May 2000 | WO |
WO 0067846 | Nov 2000 | WO |
WO 0071207 | Nov 2000 | WO |
WO 0076406 | Dec 2000 | WO |
Number | Date | Country | |
---|---|---|---|
60135224 | May 1999 | US |